Viewing Study NCT00156988



Ignite Creation Date: 2024-05-05 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00156988
Status: COMPLETED
Last Update Posted: 2009-08-10
First Post: 2005-09-08

Brief Title: The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns
Sponsor: Association of Dutch Burn Centres
Organization: Association of Dutch Burn Centres

Study Overview

Official Title: The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns
Status: COMPLETED
Status Verified Date: 2009-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of the proposed study is to assess whether the application of flammacerium for 2 days is as good as or even better than the application of flammacerium for 10 days regarding woundhealing in partial thickness burns
Detailed Description: Cerium is suggested to halt the cytokine cascade ensuing burn injury by binding the burn toxin and when used in combination with silver-sulfadiazine may enhance its antibacterial effect Since 1984 the combination of cerium and silver sulfadiazine flammacerium has been used in our centre Current practice is to treat acute non-facial burns with daily cleaning and re-application of flammacerium for a total of ten days However prolonged application of cerium is thought to be unnecessary - it is effective in the early stages after injury- and prolonged application of silver sulfadiazine has a negative effect on wound healing The objective of the proposed study is therefore to assess whether the application of flammacerium for 2 days is as good as or even better than the application of flammacerium for 10 days regarding woundhealing in partial thickness burns

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
WOP04103 None None None